Esther Tarrab
Overview
Explore the profile of Esther Tarrab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Condotta S, Downey J, Pardy R, Valbon S, Tarrab E, Lamarre A, et al.
Immunohorizons
. 2020 Apr;
4(4):217-230.
PMID: 32332052
CD8 T cell-mediated immunity is critical for host defense against viruses and requires mitochondria-mediated type I IFN (IFN-I) signaling for optimal protection. Cyclophilin D (CypD) is a mitochondrial matrix protein...
2.
Chartrand K, LeBel M, Tarrab E, Savard P, Leclerc D, Lamarre A
Front Immunol
. 2018 Jan;
8:1885.
PMID: 29354118
Although vaccination has been an effective way of preventing infections ever since the eighteenth century, the generation of therapeutic vaccines and immunotherapies is still a work in progress. A number...
3.
Lapierre P, Janelle V, Langlois M, Tarrab E, Charpentier T, Lamarre A
Cell Mol Gastroenterol Hepatol
. 2017 Feb;
1(3):325-341.e1.
PMID: 28210682
Background & Aims: The constant exposure of the liver to food and bacterial antigens through the mesenteric circulation requires it to maintain tolerance while preserving the ability to mount an...
4.
Daugan M, Murira A, Mindt B, Germain A, Tarrab E, Lapierre P, et al.
Front Immunol
. 2016 Dec;
7:564.
PMID: 27994594
Elicitation of type I interferon (IFN-I) has been shown to both enhance and impair cell-mediated immune responses in acute and persistent viral infections, respectively. Here, we show that, in addition...
5.
LeBel M, Langlois M, Daudelin J, Tarrab E, Savard P, Leclerc D, et al.
J Immunol
. 2016 Nov;
198(1):292-299.
PMID: 27864474
The increasing use of plant viruses for the development of new vaccines and immunotherapy approaches poses questions regarding the mechanism by which the mammalian immune system recognizes these viruses. For...
6.
Laroche-Lefebvre C, Yousefi M, Daudelin J, Charpentier T, Tarrab E, Klinck R, et al.
J Immunol
. 2016 Sep;
197(9):3618-3627.
PMID: 27664281
Diverse signals received by CD8 T cells are integrated to achieve the required magnitude of cell expansion and the appropriate balance of effector/memory CD8 T cell generation. Notably, the strength...
7.
LeBel M, Chartrand K, Tarrab E, Savard P, Leclerc D, Lamarre A
Nano Lett
. 2016 Feb;
16(3):1826-32.
PMID: 26891174
The recent development of novel immunotherapies is revolutionizing cancer treatment. These include, for example, immune checkpoint blockade, immunomodulation, or therapeutic vaccination. Although effective on their own, combining multiple approaches will...
8.
Janelle V, Langlois M, Tarrab E, Lapierre P, Poliquin L, Lamarre A
Cancer Immunol Res
. 2014 Apr;
2(3):200-6.
PMID: 24778316
Although the role of the complement system in cancer development has been studied, its involvement in the development of an antitumoral immune response remains poorly understood. Using cobra venom factor...
9.
LeBel M, Daudelin J, Chartrand K, Tarrab E, Kalinke U, Savard P, et al.
J Immunol
. 2013 Dec;
192(3):1071-8.
PMID: 24376264
Developing new adjuvants and vaccination strategies is of paramount importance to successfully fight against many life-threatening infectious diseases and cancer. Very few adjuvants are currently authorized for human use, and...
10.
Tarrab E, Huet P, Brault A, Rocheleau B, Laurens M, Crenesse D
J Surg Res
. 2011 Jun;
175(2):333-42.
PMID: 21696775
Cyclosporin-A (CsA) has been reported to protect livers from warm ischemia/reperfusion (I/R) injury. To study if CsA has also a protective effect on cold I/R injury, two models were used:...